|Day's Range||33.65 - 33.99|
|52 Week Range||29.83 - 37.39|
|PE Ratio (TTM)||28.41|
|Dividend & Yield||1.28 (3.76%)|
|1y Target Est||N/A|
Pfizer's gross margin for 1Q17 was 81.0%, a 0.70% rise compared to 80.3% in 1Q16.
The Innovative Health segment reported a 9.0% rise in 1Q17 revenues compared to 1Q16 revenues from sales in the US markets.
Pfizer Innovative Health contributed $7.4 billion, or about 58.0% of Pfizer's total revenues in 1Q17.